These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23644970)

  • 1. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis.
    Pola S; Fahmy M; Evans E; Tipps A; Sandborn WJ
    Am J Gastroenterol; 2013 May; 108(5):857-8. PubMed ID: 23644970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenous colitis with unique colonoscopic findings.
    Hashimoto Y; Endo Y; Kuroki Y; Yoshikumi H; Yoshiba M
    Endoscopy; 2008 Sep; 40 Suppl 2():E162. PubMed ID: 18668451
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomembranous collagenous colitis.
    Denız K; Coban G; Ozbakir O; Denız E
    Turk J Gastroenterol; 2012 Feb; 23(1):93-5. PubMed ID: 22505393
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
    Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
    Fratila OC; Craciun C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for refractory ulcerative colitis.
    Chey WY; Hussain A; Ryan C; Potter GD; Shah A
    Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
    Tonnel AB; Denis G; Lelong J
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory diseases of the intestines].
    Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
    Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimal maintenance treatment for ulcerative colitis?
    Cohen RD
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S236-7. PubMed ID: 18816679
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
    Sandborn WJ; Rutgeerts P; Feagan BG; Reinisch W; Olson A; Johanns J; Lu J; Horgan K; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Present D; Sands BE; Colombel JF
    Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological therapy in children with inflammatory bowel syndrome (clinical cases)].
    Alieva ÉI
    Eksp Klin Gastroenterol; 2014; (1):110-2. PubMed ID: 25518466
    [No Abstract]   [Full Text] [Related]  

  • 18. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
    Harbord M; Eliakim R; Bettenworth D; Karmiris K; Katsanos K; Kopylov U; Kucharzik T; Molnár T; Raine T; Sebastian S; de Sousa HT; Dignass A; Carbonnel F;
    J Crohns Colitis; 2017 Jul; 11(7):769-784. PubMed ID: 28513805
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab for ulcerative colitis following liver transplantation.
    Lal S; Steinhart AH
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
    Trinder MW; Lawrance IC
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.